Espańol | English












 
 

 

Links & Links is a group of medical experts in healthcare systems, public health (epidemiology), academics and health economists that offers diverse services based on DISEASE MANAGEMENT, HEALTH ECONOMICS y ACCESS MARKET for the healthcare market. We are experts in highly specialized markets and access markets in the public and private sectors.

  • We are pioneers in Mexico and Latin America in Disease Management, Health Economics & Outcome Research
  • Experience, excellence and quality services for 15 years, backed by more than 60 clients in the healthcare market in Mexico and Latin America: pharmaceutical industry, insurance companies, public institutes, private institutes, political parties, consortiums and hospitals.
  • Authors of a large collection of academic publications, abstracts and podium presentations, with recognition through ten awards in international conventions
  • Founders of the ISPOR chapter in Mexico, members of the editorial committee of ISPOR International, members of the American College of Healthcare Executives, members of the Global Health Economics Network, members of the HEOR (Health Economics & Outcome Research) Society.
  • In the last six year period, we worked with 70% of the codes included on the inter-institute basic formulary.
 
 

Our Vision is an approach based on Disease Management and our mission is that all decision makers in the healthcare industry be familiar with this approach, our services and our database in MEXICO and LATIN AMERICA to make better decisions by optimizing and maximizing resources.

Through our diverse services, we offer an insurmountable value chain for DISEASE MANAGEMENT, HEALTH ECONOMICS & ACCESS MARKET strategies in both the private sector and government sector. Our services enable our clients to achieve a strategic and tactical planning platform for healthcare in which we can accompany them from the first phases of planning the product to entrance in accessible PRIVATE and PUBLIC markets.

The company was founded 15 years ago by Dr. Alfonso Antonio Rosado Buzzo (cardiologist with a masters in business administration and masters in public administration, doctorate in healthcare systems, ample experience in the National Healthcare System, Supranational Healthcare System (World Bank) and pharmaceutical industry, and an expert in Disease Management, Health Economics and Access Market) and Dr. Lourdes García Mollinedo (cardiologist with a masters in business administration, postgraduate studies in Edmonton, Canada, and in the United States, and ample experience in the National Healthcare System and the pharmaceutical industry, and an expert in Health Economics, Disease Management and Access Market).

Through the DISEASE MANAGEMENT approach (figure 1) - that is, in-depth knowledge of the disease and the interrelated forces between the patient, financier and service provider – we can visualize, create and specify opportunities for the pharmaceutical product

 

 

V 1.0